Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Bivalent mRNA booster effective, 'essential' for older adults
Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19
Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios | Reuters
Plug and Play” mRNA technology works fast, updating vaccines in months : Oregon Health News Blog
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Moderna on X: "A 50 µg #booster dose of our first bivalent booster #vaccine candidate, mRNA-1273.211, demonstrated superiority against Beta, Delta and #Omicron variants of concern one month after administration, and superiority
Vaccines | Free Full-Text | Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults - The Lancet Infectious Diseases
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 | Nature Communications
How to choose a COVID-19 vaccine booster shot
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Third COVID-19 mRNA vaccine booster dose indicated for myelofibrosis patients
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Study backs efficacy of half-dosage mRNA booster| สำนักข่าวกรมประชาสัมพันธ์
Does a second monovalent SARS-CoV-2 mRNA booster increase neutralizing activity to Omicron variants in nursing home residents and healthcare workers?
Pfizer (PFE), Moderna (MRNA) Covid Booster Vaccines Greenlighted by CDC Panel - Bloomberg
Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study - The Lancet Regional Health – Europe
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
More adverse reactions following bivalent COVID-19 mRNA booster vaccine
RACGP - Four things about mRNA vaccines researchers still want to find out
Vaccines | Free Full-Text | mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
